BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32892682)

  • 1. Prognostic significance of thrombocytosis in lung cancer: a systematic review and meta-analysis.
    Ma Y; Li G; Yu M; Sun X; Nian J; Gao Y; Li X; Ding T; Wang X
    Platelets; 2021 Oct; 32(7):919-927. PubMed ID: 32892682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
    Ye Q; Cheng J; Ye M; Liu D; Zhang Y
    J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the prognostic value of platelet-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis.
    Yang L; Chen H
    Int J Gynecol Cancer; 2019 May; 29(4):683-690. PubMed ID: 30739081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment thrombocytosis predicts prognosis of endometrial cancer: A meta-analysis of 11 studies.
    Ye Q; Wu Z; Xia T; Liu D; Yang Y; Tang H
    Exp Ther Med; 2020 Jan; 19(1):359-366. PubMed ID: 31853312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
    Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
    [No Abstract]   [Full Text] [Related]  

  • 6. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
    Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
    BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytosis Portends Adverse Prognosis in Colorectal Cancer: A Meta-Analysis of 5,619 Patients in 16 Individual Studies.
    Gu D; Szallasi A
    Anticancer Res; 2017 Sep; 37(9):4717-4726. PubMed ID: 28870890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
    Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
    Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis.
    Zhuo Y; Lin L; Zhang M
    Platelets; 2017 Sep; 28(6):560-566. PubMed ID: 27848258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: a systematic review and meta-analysis.
    Cao W; Yao X; Cen D; Zhi Y; Zhu N; Xu L
    World J Surg Oncol; 2019 Aug; 17(1):132. PubMed ID: 31375109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
    Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
    BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis.
    Yang T; Hao L; Yang X; Luo C; Wang G; Lin Cai C; Qi S; Li Z
    BMJ Open; 2021 Sep; 11(9):e049123. PubMed ID: 34475167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis.
    Cheng J; Zeng Z; Ye Q; Zhang Y; Yan R; Liang C; Wang J; Li M; Yi M
    Oncotarget; 2017 Apr; 8(15):24327-24336. PubMed ID: 28212582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment thrombocytosis predict poor prognosis in patients with endometrial carcinoma: a systematic review and meta-analysis.
    Nie D; Yang E; Li Z
    BMC Cancer; 2019 Jan; 19(1):73. PubMed ID: 30646853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Chen X; Meng F; Jiang R
    Front Oncol; 2021; 11():746976. PubMed ID: 34900692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis.
    Hua X; Chen J; Wu Y; Sha J; Han S; Zhu X
    World J Surg Oncol; 2019 Nov; 17(1):177. PubMed ID: 31677642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Prealbumin in Liver Cancer: A Systematic Review and Meta-Analysis.
    Qiao W; Leng F; Liu T; Wang X; Wang Y; Chen D; Wei J
    Nutr Cancer; 2020; 72(6):909-916. PubMed ID: 31507226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of Twist in lung cancer: systematic review and meta-analysis.
    Zeng J; Zhan P; Wu G; Yang W; Liang W; Lv T; Song Y
    Transl Lung Cancer Res; 2015 Jun; 4(3):236-41. PubMed ID: 26207211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis.
    Yuan Y; Zhong H; Ye L; Li Q; Fang S; Gu W; Qian Y
    BMC Pulm Med; 2020 Apr; 20(1):96. PubMed ID: 32312252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.